iHuman Current Cash

The latest current cash for IH is $800M as of June 2026. That compares with $610M in the prior-year period — up 31.6% year over year. Investors often review this figure alongside iHuman's historical trend and sector peers before judging valuation or financial health.

Over the past year, IH's current cash moved from $610M to $800M — a 31.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in iHuman's operating scale or balance-sheet position.

A current cash figure of $800M for IH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IH's current cash ($800M), review year-over-year change from $610M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.